Who is sponsoring NCT05590650?

NCT05590650 is sponsored by China Medical University Hospital.

What drugs are being tested in NCT05590650?

Interventions in NCT05590650: SZKJT(San-Zhong-Kui-Jian-Tang).

What condition does NCT05590650 study?

NCT05590650 studies Head and Neck Neoplasm, Chemoradiotherapy.

Is NCT05590650 still recruiting?

NCT05590650 is currently completed. Last updated 26 October 2022.

Last reviewed 2022-10-26 · How we verify

NCT05590650

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients

Completed Phase 1 Last updated 26 October 2022

What this trial tests

Phase 1 trial testing SZKJT(San-Zhong-Kui-Jian-Tang) in Head and Neck Neoplasm in 21 participants. Completed in 25 December 2020.

Timeline

7 July 2018

Primary endpoint
14 June 2020

25 December 2020

Quick facts

Lead sponsor	China Medical University Hospital
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	21
Start date	7 July 2018
Primary completion	14 June 2020
Estimated completion	25 December 2020
Sites	1 location across Taiwan

Drugs / interventions tested

SZKJT(San-Zhong-Kui-Jian-Tang) — full drug profile →

Conditions studied

Head and Neck Neoplasm — all drugs for Head and Neck Neoplasm →
Chemoradiotherapy — all drugs for Chemoradiotherapy →

Sponsor

China Medical University Hospital

Who can join

Adults 20 to 65, any sex, with Head and Neck Neoplasm or Chemoradiotherapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to learn about the clinical efficacy of San-Zhong-Kui-Jian-Tang (SZKJT), a formula of Chinese medicine in head and neck cancer patients receiving concurrent chemoradiotherapy (CCRT) treatments. The main questions it aims to answer are: * Can SZKJT improve the completion rate of CCRT? * Can SZKJT reduce the adverse effects of CCRT? * How SZKJT affect the quality of life in the patients receiving CCRT * How about the safety of using SZKJT in the patients receiving CCRT Participants will be asked to: * take SZKJT for 9 weeks during the whole CCRT course * take questionnaires of quality of life

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Chinese Herbal Medicine for Concurrent Chemoradiation-Induced Adverse Events in Head and Neck Cancer Patients: A Prospective Feasibility Study.
Tang HT, Ou SC, Chu CL, Lee AL, et al · · 2025 · PMID 40123292 · DOI 10.1177/15347354251326946

Verify or expand the search:

Other recruiting trials for Head and Neck Neoplasm

Currently open trials in the same condition.

NCT04099290 — Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma · recruiting
NCT06356272 — Oropharynx (OPX) Biomarker Trial · recruiting
NCT04005521 — Randomized Study Regarding Preventive Jaw- and Swallowing Intervention for Patients With Head and Neck Cancer · NA · active not recruiting
NCT03840421 — GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma · Phase 3 · active not recruiting

Other China Medical University Hospital trials

Trials by the same sponsor.

NCT07525700 — The Effects of Combining Electronic Picture Books With RPG-Based Gamified Learning on Nursing Students' Motivation and L · NA · not yet recruiting
NCT07463391 — Chinese Classics Recitation Training in Subjective Cognitive Decline · NA · not yet recruiting
NCT07482189 — Effectiveness and Efficiency of an Upper Limb Active-Passive Exoskeleton Robot in Patients With Frozen Shoulder · NA · not yet recruiting
NCT07437144 — Exploring the Effects of Shangshou Daoyin Method on Improving Sleep Quality, Quality of Life, and TCM Constitution in Br · NA · not yet recruiting
NCT07232667 — Digital Technology for Active and Healthy Ageing in Taiwan · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05590650 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by China Medical University Hospital
Last refreshed: 26 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05590650.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing